Monthly News Roundup - July 2021

Kerendia Cleared to Treat Chronic Kidney Disease Linked with Type 2 Diabetes
In July, the FDA approved Bayer’s Kerendia (finerenone) from Bayer, a first-in-class non-steroidal, selective mineralocorticoid receptor antagonist (MRA) for the...

Source: Drugs.com - Pharma News - July 31, 2021 Category: Pharmaceuticals Source Type: news